Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Fluoxetine
Drug ID BADD_D00932
Description Fluoxetine is a 2nd generation antidepressant categorized as a selective serotonin reuptake inhibitor (SSRI).[A181673] It gained FDA approval in 1987 and although it was initially intended for the treatment of depression, today it is commonly prescribed to manage depression in addition to various other pathologies.[L7721]
Indications and Usage Fluoxetine is indicated for both acute and maintenance treatment of major depressive disorder, obsessive compulsive disorder, and bulimia nervosa; however, it is only indicated for acute treatment of panic disorder independent of whether agoraphobia is present.[L7664] Fluoxetine may also be used in combination with olanzapine to treat depression related to Bipolar I Disorder, and treatment resistant depression.[L7664]
Marketing Status approved; vet_approved
ATC Code N06AB03
DrugBank ID DB00472
KEGG ID D00326
MeSH ID D005473
PubChem ID 3386
TTD Drug ID D0TR5X
NDC Product Code 0093-0807; 43063-839; 53002-2305; 61919-869; 62332-243; 71335-0924; 0615-8093; 0093-7198; 50090-3180; 50111-647; 50228-421; 59651-308; 68645-130; 0615-7625; 72241-009; 0904-5785; 0904-7195; 49884-468; 55111-150; 59651-324; 62332-242; 65862-306; 71209-041; 61919-885; 63304-632; 72241-008; 80426-044; 63187-233; 63629-8179; 70518-3752; 71335-0565; 80425-0313; 59651-309; 13668-443; 46708-273; 68645-131; 80426-045; 23155-028; 23155-030; 42291-398; 42571-388; 62332-024; 63187-089; 71335-1048; 0904-5784; 23155-029; 42291-396; 42571-389; 62332-022; 72162-1506; 72241-007; 16714-112; 16714-113; 42291-397; 42571-387; 43598-566; 46708-272; 50228-420; 58118-0645; 70518-1619; 71209-042; 13668-473; 50111-648; 55154-1341; 61919-100; 62332-023; 63629-2201; 71205-178; 71205-188; 71209-040; 42708-025; 46708-271; 53002-5016
UNII 01K63SUP8D
Synonyms Fluoxetine | Fluoxetin | N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine | Lilly-110140 | Lilly 110140 | Lilly110140 | Sarafem | Fluoxetine Hydrochloride | Prozac
Chemical Information
Molecular Formula C17H18F3NO
CAS Registry Number 54910-89-3
SMILES CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Asthma10.01.03.010; 22.03.01.0020.000217%-
Ataxia08.01.02.004; 17.02.02.0010.000073%
Atelectasis22.01.02.0010.000020%
Atrial fibrillation02.03.03.002--
Atrial flutter02.03.03.0030.000089%
Atrial tachycardia02.03.03.0040.000030%
Atrioventricular block02.03.01.002---
Atrioventricular block first degree02.03.01.004--
Atrophy08.03.04.0010.000020%-
Azoospermia21.03.03.001--
Back pain15.03.04.005--
Biliary colic09.02.01.001---
Bipolar I disorder19.16.01.0020.000049%-
Bladder pain20.02.02.001---
Bleeding time prolonged13.01.02.002---
Blepharitis06.04.04.001; 23.03.04.012---
Blepharospasm06.05.01.001; 17.17.02.0010.000030%-
Blindness06.02.10.003; 17.17.01.0030.000069%-
Blindness unilateral06.02.10.007; 17.17.01.0160.000039%-
Blister12.01.06.002; 23.03.01.001---
Blood creatine phosphokinase increased13.04.01.001--
Blood pressure increased13.14.03.005---
Blood urea increased13.13.01.006---
Blood uric acid increased13.02.04.001---
Body temperature decreased13.15.01.010---
Body temperature increased13.15.01.001---
Bone development abnormal15.02.04.0030.000020%-
Bone disorder15.02.04.004---
Bone pain15.02.01.001--
Bradycardia02.03.02.0020.000295%-
The 3th Page    First    Pre   3 4 5 6 7    Next   Last    Total 35 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene